Sep 11, 2022Acceptance in Major Peer-Reviewed Journals of two Landmark Pre-Clinical StudiesAlpha Tau Announces the Acceptance in Major Peer-Reviewed Journals (International Journal of Radiation Oncology, Biology, Physics, and...
Sep 6, 2022Alpha Tau Appoints Industry Veteran Peter Melnyk as Chief Commercial OfficerJERUSALEM, September 1, 2022 -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation...